Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1/2 1Phase 1 1

Status

Recruiting 2Completed 2Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Hematuria 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × Cystoscopy × Clear all
NCT05362539 2022-05-05

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

Mansoura University

Phase NA Completed
246 enrolled
Genitourinary

Urinary Bladder Neoplasms, Hematuria

NCT02700464 2021-05-04

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

Nucleix Ltd.

Phase NA Completed
680 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡